Distributed automated manufacturing of pluripotent stem cell products

Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its challenges are recognised by healthcare regulators with deviations and comparability issues receiving specific attention from them. This paper is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Adv Manuf Technol
Hauptverfasser: Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer London 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954896/
https://ncbi.nlm.nih.gov/pubmed/31983799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00170-019-04516-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge